112. Thalassemia and Globin Gene Regulation: Poster I

Luspatercept in β thalassemia Meta analysis of efficacy and safety across transfusion dependent and non transfusion dependent populations

Oral glucose tolerance test remains the gold standard for diagnosis of glucose metabolism disturbances in thalassemia patients

Thrombophilia testing and thrombotic risk evaluation in beta thalassemia A cohort analysis from a hub regional center

A clinical study on the Efficacy and safety of luspatercept in Chinese patients with non transfusion dependent β thalassemia

High morbidity in adults with non transfusion dependent thalassemia referred to u S specialty centers

Revisiting erythroid response in the phase 3 BELIEVE trial of luspatercept in patients with transfusion dependent β thalassemia using real world criteria

Chromameter measured skin lightness A novel noninvasive marker for liver iron in thalassemia patients

A genome wide CRISPR activation screen identifies novel γ globin regulators

Safety data from the non transfusion dependent dose confirmation cohort A phase 2a study of luspatercept in pediatric patients with β thalassemia